ERCC2 and cancer: These findings indicate that Lys751Gln ERCC2/XPD polymorphism influences the capacity of DNA repair upon exposure to carcinogens, such as B[a]P, in this controlled in vitro system, and can act as a biomarker enhancing the prognostic value of cancer development.